ENDRA Life Sciences (NDRA) Q2 2021 Earnings Report

861 Followers

NDRA Q2 2021 EPS Results

Actual EPS: -$2,800.00
Consensus EPS: -$2,450.00
Beat/Miss: Missed by -$350.00
One Year Ago EPS: -$7,000.00

NDRA Q2 2021 Revenue Results

Actual Revenue: $0
Expected Revenue: $0
Beat/Miss: Met expectations
YoY Revenue Growth: ―

Earnings Announcement Details

Quarter: Q2 2021
Date: 08/12/2021
Time: After Close
Conference Call: Thursday, August 12, 2021

NDRA Upcoming Earnings

ENDRA Life Sciences's next earnings date is estimated for November 16, 2026, based on past reporting schedules.

Q2 2021 Earnings Call Audio

No earnings call audio is available for this earnings event.

Q2 2021 Earnings Slide Deck

No slide deck is available for this earnings event.

Q2 2021 Earnings Call Summary

No earnings call summary is available for this earnings event.

NDRA Earnings History

NDRA earnings history
Report Date	Fiscal Quarter	Forecast / EPS	Last Year's EPS	EPS YoY Change	Press Release
Nov 16, 2026	2026 (Q3)	-0.84-	-2.1	―	―
Aug 17, 2026	2026 (Q2)	-0.840.12	-1.71	107.08% (+1.83)
May 18, 2026	2026 (Q1)	―-1.09	-1.86	41.40% (+0.77)
Mar 31, 2026	2025 (Q4)	-1.23-1.09	-1.86	41.40% (+0.77)
Nov 17, 2025	2025 (Q3)	-1.95-2.10	-9.54	77.99% (+7.44)
Jun 30, 2025	2025 (Q2)	-2.27-1.71	-140	98.78% (+138.29)
May 15, 2025	2025 (Q1)	―-1.86	-455	99.59% (+453.14)
Mar 31, 2025	2024 (Q4)	-3.91-1.86	-455	99.59% (+453.14)
Nov 15, 2024	2024 (Q3)	-62.30-9.54	-700	98.64% (+690.46)
Aug 22, 2024	2024 (Q2)	-122.50-140.00	-752.5	81.40% (+612.50)
May 14, 2024	2024 (Q1)	-472.50-455.00	-1627.5	72.04% (+1172.50)
Mar 28, 2024	2023 (Q4)	-630.00-297.50	-1820	83.65% (+1522.50)
Nov 14, 2023	2023 (Q3)	-752.50-700.00	-1750	60.00% (+1050.00)
Aug 14, 2023	2023 (Q2)	-962.50-752.50	-2100	64.17% (+1347.50)
May 15, 2023	2023 (Q1)	-1828.75-1627.50	-2450	33.57% (+822.50)
Mar 14, 2023	2022 (Q4)	-1575.00-1820.00	-2450	25.71% (+630.00)
Nov 14, 2022	2022 (Q3)	-1925.00-1750.00	-2100	16.67% (+350.00)
Aug 15, 2022	2022 (Q2)	-1925.00-2100.00	-2800	25.00% (+700.00)
May 12, 2022	2022 (Q1)	-2625.00-2450.00	-2100	-16.67% (-350.00)
Mar 30, 2022	2021 (Q4)	-2800.00-2450.00	-3500	30.00% (+1050.00)
Nov 15, 2021	2021 (Q3)	-2800.00-2100.00	-5250	60.00% (+3150.00)
Aug 12, 2021	2021 (Q2)	-2450.00-2800.00	-7000	60.00% (+4200.00)
May 17, 2021	2021 (Q1)	―-2100.00	-10150	79.31% (+8050.00)
Mar 25, 2021	2020 (Q4)	―-3500.00	-40250	91.30% (+36750.00)
Nov 16, 2020	2020 (Q3)	―-5250.00	-16100	67.39% (+10850.00)
Aug 14, 2020	2020 (Q2)	―-4.00	-6.2	35.48% (+2.20)
May 14, 2020	2020 (Q1)	―-5.80	-7.4	21.62% (+1.60)
Mar 26, 2020	2019 (Q4)	―-23.00	-7.4	-210.81% (-15.60)
Nov 13, 2019	2019 (Q3)	―-9.20	-14.05	34.50% (+4.85)
Aug 08, 2019	2019 (Q2)	―-6.20	-9.41	34.15% (+3.21)
May 14, 2019	2019 (Q1)	―-7.40	-14.4	48.63% (+7.00)
Mar 11, 2019	2018 (Q4)	―-7.40	-11.7	36.74% (+4.30)
Nov 05, 2018	2018 (Q3)	―-0.70	-0.23	-205.22% (-0.47)
Aug 13, 2018	2018 (Q2)	―-0.47	-0.59	20.17% (+0.12)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat Missed

ENDRA Life Sciences earnings date